A detailed history of Fiduciary Group LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Fiduciary Group LLC holds 25,226 shares of BMY stock, worth $1.36 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
25,226
Previous 28,023 9.98%
Holding current value
$1.36 Million
Previous $1.52 Million 31.07%
% of portfolio
0.11%
Previous 0.17%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$40.25 - $52.99 $112,579 - $148,213
-2,797 Reduced 9.98%
25,226 $1.05 Million
Q1 2024

May 13, 2024

SELL
$47.98 - $54.4 $13,578 - $15,395
-283 Reduced 1.0%
28,023 $1.52 Million
Q4 2023

Feb 05, 2024

SELL
$48.48 - $57.85 $54,830 - $65,428
-1,131 Reduced 3.84%
28,306 $1.45 Million
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $18,698 - $20,907
-323 Reduced 1.09%
29,437 $1.71 Million
Q2 2023

Jul 27, 2023

BUY
$63.71 - $70.74 $5,606 - $6,225
88 Added 0.3%
29,760 $1.9 Million
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $11,630 - $13,191
-177 Reduced 0.59%
29,672 $2.06 Million
Q4 2022

Feb 07, 2023

SELL
$68.48 - $81.09 $58,618 - $69,413
-856 Reduced 2.79%
29,849 $2.15 Million
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $67 - $39,956
520 Added 1.72%
30,705 $2.44 Million
Q2 2022

Aug 12, 2022

BUY
$72.62 - $79.98 $226,066 - $248,977
3,113 Added 11.5%
30,185 $2.32 Million
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $5,102 - $6,118
83 Added 0.31%
27,072 $2.06 Million
Q3 2021

Oct 27, 2021

SELL
$59.17 - $69.31 $31,064 - $36,387
-525 Reduced 1.91%
26,989 $1.57 Million
Q2 2021

Aug 05, 2021

SELL
$61.91 - $67.42 $13,929 - $15,169
-225 Reduced 0.81%
27,514 $1.88 Million
Q1 2021

May 03, 2021

SELL
$59.34 - $66.74 $17,802 - $20,022
-300 Reduced 1.07%
27,739 $1.73 Million
Q4 2020

Feb 12, 2021

SELL
$57.74 - $65.43 $7,332 - $8,309
-127 Reduced 0.45%
28,039 $1.68 Million
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $29,876 - $34,929
-545 Reduced 1.9%
28,166 $1.66 Million
Q1 2020

May 11, 2020

SELL
$46.4 - $67.43 $30,624 - $44,503
-660 Reduced 2.25%
28,711 $1.6 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $16,239 - $21,182
330 Added 1.14%
29,371 $1.89 Million
Q3 2019

Nov 13, 2019

SELL
$42.77 - $50.71 $22,283 - $26,419
-521 Reduced 1.76%
29,041 $1.47 Million
Q2 2019

Aug 05, 2019

SELL
$44.62 - $49.34 $16,375 - $18,107
-367 Reduced 1.23%
29,562 $1.34 Million
Q1 2019

May 08, 2019

SELL
$45.12 - $53.8 $36,096 - $43,040
-800 Reduced 2.6%
29,929 $1.43 Million
Q4 2018

Feb 13, 2019

SELL
$48.76 - $63.23 $109,222 - $141,635
-2,240 Reduced 6.79%
30,729 $1.6 Million
Q3 2018

Oct 18, 2018

BUY
$55.19 - $62.25 $229,038 - $258,337
4,150 Added 14.4%
32,969 $2.05 Million
Q2 2018

Aug 02, 2018

SELL
$50.53 - $62.98 $118,745 - $148,003
-2,350 Reduced 7.54%
28,819 $1.6 Million
Q1 2018

May 14, 2018

SELL
$59.92 - $68.98 $90,479 - $104,159
-1,510 Reduced 4.62%
31,169 $1.97 Million
Q4 2017

Feb 02, 2018

SELL
$59.94 - $65.35 $36,263 - $39,536
-605 Reduced 1.82%
32,679 $2 Million
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $1.84 Million - $2.12 Million
33,284
33,284 $2.12 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Fiduciary Group LLC Portfolio

Follow Fiduciary Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Group LLC with notifications on news.